Lam Research (LRCX) is down 6.7% today. Here is some analysis on what might have caused this price movement.
Analysis: The most likely driver is a broad semiconductor-equipment selloff rather than a Lam-specific corporate setback. Investors appear to be reassessing AI infrastructure and wafer-fab equipment demand after renewed pressure on chip names tied to softer-than-hoped monthly revenue momentum at a major foundry customer, while Lam’s rich valuation left the shares vulnerable to profit-taking. ([investing.com](https://www.investing.com/news/stock-market-news/why-is-lam-research-stock-tumbling-today-93CH-4779570?utm_source=openai))
Details:
Sources:
Investing.com, TSMC Investor Relations, Lam Research Investor Relations
Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.
$LRCX Insider Trading Activity
$LRCX insiders have traded $LRCX stock on the open market 53 times in the past 6 months. Of those trades, 0 have been purchases and 53 have been sales.
Here’s a breakdown of recent trading of $LRCX stock by insiders over the last 6 months:
- ERIC BRANDT has made 0 purchases and 45 sales selling 144,000 shares for an estimated $47,025,855.
- DOUGLAS R BETTINGER (Chief Financial Officer & EVP) has made 0 purchases and 2 sales selling 90,386 shares for an estimated $20,498,812.
- TIMOTHY ARCHER (President and CEO) sold 30,000 shares for an estimated $11,700,300
- NEIL J FERNANDES (Senior Vice President) has made 0 purchases and 2 sales selling 25,829 shares for an estimated $7,007,120.
- AVA HARTER (Chief Legal Officer) has made 0 purchases and 3 sales selling 11,510 shares for an estimated $2,818,536.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$LRCX Hedge Fund Activity
We have seen 1,137 institutional investors add shares of $LRCX stock to their portfolio, and 1,048 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC added 6,893,278 shares (+25.8%) to their portfolio in Q1 2026, for an estimated $1,417,947,284
- GOLDMAN SACHS GROUP INC removed 4,359,777 shares (-29.4%) from their portfolio in Q1 2026, for an estimated $896,806,128
- CORIENT PRIVATE WEALTH LLC removed 4,093,544 shares (-78.7%) from their portfolio in Q1 2026, for an estimated $842,042,000
- J. STERN & CO. LLP removed 3,439,713 shares (-99.4%) from their portfolio in Q1 2026, for an estimated $707,548,964
- CITADEL ADVISORS LLC removed 3,126,734 shares (-73.7%) from their portfolio in Q1 2026, for an estimated $643,169,183
- ARTISAN PARTNERS LIMITED PARTNERSHIP removed 2,921,363 shares (-36.7%) from their portfolio in Q1 2026, for an estimated $600,924,369
- JENNISON ASSOCIATES LLC added 2,523,351 shares (+296.9%) to their portfolio in Q1 2026, for an estimated $519,053,300
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$LRCX Congressional Stock Trading
Members of Congress have traded $LRCX stock 11 times in the past 6 months. Of those trades, 2 have been purchases and 9 have been sales.
Here’s a breakdown of recent trading of $LRCX stock by members of Congress over the last 6 months:
- REPRESENTATIVE DAVID TAYLOR has traded it 9 times. They made 1 purchase worth up to $15,000 on 03/12 and 8 sales worth up to $190,000 on 06/05, 04/27, 02/26, 01/16, 01/08.
- REPRESENTATIVE CLEO FIELDS purchased up to $50,000 on 02/03.
- SENATOR JOHN BOOZMAN sold up to $15,000 on 01/08.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.
$LRCX Analyst Ratings
Wall Street analysts have issued reports on $LRCX in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Needham issued a "Buy" rating on 01/29/2026
- Goldman Sachs issued a "Buy" rating on 01/29/2026
- RBC Capital issued a "Outperform" rating on 01/15/2026
- Wells Fargo issued a "Overweight" rating on 01/15/2026
- Bernstein issued a "Outperform" rating on 01/12/2026
- Mizuho issued a "Outperform" rating on 01/09/2026
To track analyst ratings and price targets for $LRCX, check out Quiver Quantitative's $LRCX forecast page.
$LRCX Price Targets
Multiple analysts have issued price targets for $LRCX recently. We have seen 22 analysts offer price targets for $LRCX in the last 6 months, with a median target of $337.5.
Here are some recent targets:
- Shane Brett from Morgan Stanley set a target price of $404.0 on 07/06/2026
- Mehdi Hosseini from Susquehanna set a target price of $475.0 on 06/30/2026
- C.J. Muse from Cantor Fitzgerald set a target price of $500.0 on 06/29/2026
- Vivek Arya from B of A Securities set a target price of $480.0 on 06/23/2026
- Joe Quatrochi from Wells Fargo set a target price of $450.0 on 06/22/2026
- Atif Malik from Citigroup set a target price of $450.0 on 06/17/2026
- Ed Yang from Oppenheimer set a target price of $400.0 on 06/15/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
